Traws Ptb Ratio vs Capex To Depreciation Analysis

TRAW Stock   8.67  0.21  2.36%   
Traws Pharma financial indicator trend analysis is much more than just breaking down Traws Pharma prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Traws Pharma is a good investment. Please check the relationship between Traws Pharma Ptb Ratio and its Capex To Depreciation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.

Ptb Ratio vs Capex To Depreciation

Ptb Ratio vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Traws Pharma Ptb Ratio account and Capex To Depreciation. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Traws Pharma's Ptb Ratio and Capex To Depreciation is -0.1. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Traws Pharma, assuming nothing else is changed. The correlation between historical values of Traws Pharma's Ptb Ratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Traws Pharma are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Ptb Ratio i.e., Traws Pharma's Ptb Ratio and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

-0.1
Relationship DirectionNegative 
Relationship StrengthInsignificant

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.
Most indicators from Traws Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Traws Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.At this time, Traws Pharma's Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to climb to about 412.8 M in 2025, whereas Selling General Administrative is likely to drop slightly above 9.7 M in 2025.
 2020 2024 2025 (projected)
Total Revenue231K203.4K193.2K
Depreciation And Amortization13K18.4K15.6K

Traws Pharma fundamental ratios Correlations

-0.47-0.811.0-0.42-0.21-0.91-0.49-0.541.0-0.62-0.64-0.211.0-0.510.5-0.44-0.060.49-0.821.0-0.5-0.050.98-0.010.6
-0.470.71-0.460.580.540.230.34-0.14-0.440.620.620.54-0.440.34-0.380.64-0.55-0.590.83-0.470.18-0.56-0.4-0.59-0.65
-0.810.71-0.810.210.420.630.140.51-0.810.40.420.42-0.810.18-0.150.3-0.03-0.30.91-0.810.08-0.05-0.70.0-0.38
1.0-0.46-0.81-0.39-0.15-0.93-0.46-0.581.0-0.58-0.61-0.151.0-0.470.46-0.4-0.110.44-0.811.0-0.46-0.090.98-0.050.56
-0.420.580.21-0.390.510.20.87-0.46-0.390.960.950.51-0.390.86-0.930.97-0.72-0.930.59-0.430.78-0.73-0.48-0.78-0.96
-0.210.540.42-0.150.51-0.220.38-0.4-0.190.560.541.0-0.190.54-0.450.68-0.81-0.640.63-0.210.41-0.81-0.13-0.63-0.55
-0.910.230.63-0.930.2-0.220.310.71-0.910.370.41-0.22-0.910.28-0.310.140.42-0.220.55-0.910.320.4-0.920.27-0.36
-0.490.340.14-0.460.870.380.31-0.24-0.460.910.910.38-0.460.92-0.910.85-0.57-0.790.48-0.490.88-0.58-0.58-0.52-0.85
-0.54-0.140.51-0.58-0.46-0.40.71-0.24-0.57-0.27-0.24-0.4-0.57-0.340.38-0.480.780.460.19-0.54-0.290.78-0.490.830.33
1.0-0.44-0.811.0-0.39-0.19-0.91-0.46-0.57-0.59-0.62-0.191.0-0.490.47-0.41-0.10.46-0.811.0-0.48-0.080.98-0.040.57
-0.620.620.4-0.580.960.560.370.91-0.27-0.591.00.56-0.590.91-0.940.97-0.66-0.940.73-0.620.84-0.67-0.66-0.68-0.99
-0.640.620.42-0.610.950.540.410.91-0.24-0.621.00.54-0.620.91-0.940.96-0.63-0.940.74-0.650.84-0.64-0.69-0.66-0.99
-0.210.540.42-0.150.511.0-0.220.38-0.4-0.190.560.54-0.190.54-0.450.68-0.81-0.640.63-0.210.41-0.81-0.13-0.63-0.55
1.0-0.44-0.811.0-0.39-0.19-0.91-0.46-0.571.0-0.59-0.62-0.19-0.490.47-0.41-0.10.46-0.811.0-0.48-0.080.98-0.040.57
-0.510.340.18-0.470.860.540.280.92-0.34-0.490.910.910.54-0.49-0.970.9-0.64-0.910.53-0.520.98-0.64-0.59-0.65-0.9
0.5-0.38-0.150.46-0.93-0.45-0.31-0.910.380.47-0.94-0.94-0.450.47-0.97-0.920.620.94-0.520.51-0.950.620.590.70.95
-0.440.640.3-0.40.970.680.140.85-0.48-0.410.970.960.68-0.410.9-0.92-0.81-0.970.67-0.450.8-0.83-0.47-0.83-0.97
-0.06-0.55-0.03-0.11-0.72-0.810.42-0.570.78-0.1-0.66-0.63-0.81-0.1-0.640.62-0.810.74-0.38-0.06-0.521.0-0.060.90.66
0.49-0.59-0.30.44-0.93-0.64-0.22-0.790.460.46-0.94-0.94-0.640.46-0.910.94-0.970.74-0.660.5-0.850.750.530.840.97
-0.820.830.91-0.810.590.630.550.480.19-0.810.730.740.63-0.810.53-0.520.67-0.38-0.66-0.830.42-0.4-0.75-0.36-0.72
1.0-0.47-0.811.0-0.43-0.21-0.91-0.49-0.541.0-0.62-0.65-0.211.0-0.520.51-0.45-0.060.5-0.83-0.51-0.040.980.00.6
-0.50.180.08-0.460.780.410.320.88-0.29-0.480.840.840.41-0.480.98-0.950.8-0.52-0.850.42-0.51-0.52-0.6-0.55-0.83
-0.05-0.56-0.05-0.09-0.73-0.810.4-0.580.78-0.08-0.67-0.64-0.81-0.08-0.640.62-0.831.00.75-0.4-0.04-0.52-0.040.90.67
0.98-0.4-0.70.98-0.48-0.13-0.92-0.58-0.490.98-0.66-0.69-0.130.98-0.590.59-0.47-0.060.53-0.750.98-0.6-0.040.020.64
-0.01-0.590.0-0.05-0.78-0.630.27-0.520.83-0.04-0.68-0.66-0.63-0.04-0.650.7-0.830.90.84-0.360.0-0.550.90.020.75
0.6-0.65-0.380.56-0.96-0.55-0.36-0.850.330.57-0.99-0.99-0.550.57-0.90.95-0.970.660.97-0.720.6-0.830.670.640.75
Click cells to compare fundamentals

Traws Pharma Account Relationship Matchups

Traws Pharma fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets20.0M55.5M39.4M22.7M26.1M35.5M
Other Current Liab5.0M3.1M4.0M3.4M3.0M3.1M
Total Current Liabilities10.0M6.1M8.0M9.2M8.3M6.7M
Total Stockholder Equity6.2M46.1M28.3M10.7M12.3M22.6M
Property Plant And Equipment Net52K38K24K22K19.8K29.8K
Net Debt(19.0M)(55.1M)(38.8M)(20.8M)(18.7M)(19.7M)
Retained Earnings(428.6M)(444.7M)(463.7M)(482.6M)(434.4M)(456.1M)
Accounts Payable4.8M2.8M3.9M5.6M6.5M4.7M
Cash19.0M55.1M38.8M20.8M23.9M34.4M
Non Current Assets Total202K48K25K23K20.7K19.7K
Cash And Short Term Investments19.0M55.1M38.8M20.8M23.9M34.4M
Net Receivables37K28K29K18K16.2K15.4K
Common Stock Shares Outstanding11.6M16.8M20.9M21.0M24.1M15.7M
Liabilities And Stockholders Equity20.0M55.5M39.4M22.7M26.1M35.5M
Non Current Liabilities Total3.8M3.2M3.0M2.8M2.5M2.7M
Other Current Assets722K332K561K1.8M2.1M2.2M
Other Stockholder Equity434.6M490.6M491.8M493.1M567.1M511.3M
Total Liab13.8M9.4M11.1M12.0M10.8M9.3M
Total Current Assets19.8M55.4M39.3M22.7M26.1M35.4M
Accumulated Other Comprehensive Income14K(14K)(33K)(23K)(20.7K)(21.7K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.